Search Results - Steven Margossian
- Showing 1 - 3 results of 3
-
1
750 A phase 1 trial of CUE-102, a novel WT1-pHLA-IL2-Fc fusion protein in HLA-A*0201 positive patients with WT1-positive recurrent/metastatic cancers by Lei Zheng, Jun Gong, John Powderly, Tanios Bekaii-Saab, Angela Alistar, Siqing Fu, Nashat Gabrail, Dae Won Kim, Yvonne Saenger, Olatunji Alese, Apollina Goel, Nataliya Uboha, Laura Agensky, Matteo Levisetti, Steven Margossian, Steve Quayle, J Eva Selfridge, Jorge Chaves, Jin Zhaohui
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
2
Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children by Jennifer S. Whangbo, Haesook T. Kim, Nikola Mirkovic, Lauren Leonard, Samuel Poryanda, Sophie Silverstein, Soomin Kim, Carol G. Reynolds, Sharmila C. Rai, Kelly Verrill, Michelle A. Lee, Steven Margossian, Christine Duncan, Leslie Lehmann, Jennifer Huang, Sarah Nikiforow, Edwin P. Alyea, III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Bruce R. Blazar, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz, John Koreth
Published in Blood Advances (2019-09-01)Get full text
Article -
3
674 A phase 1 dose-escalation and expansion study of CUE-101, given as monotherapy in 3L and in combination with pembrolizumab in 1L recurrent/metastatic HPV16+ head and neck cance... by Faye Johnson, Nashat Gabrail, Ammar Sukari, Barbara Burtness, Christine H Chung, Sara Pai, Lara A Dunn, Cristina Rodriguez, Marya Chaney, Apollina Goel, Ricklie Julian, Francis Worden, Rami Haddad, Douglas Adkins, A Dimitrios Colevas, Laura Agensky, Matteo Levisetti, Steven Margossian, Steve Quayle, Jong Chul Park, Robert M Jotte, Tanguy Y Seiwert, Nabil F Saba, Julie E Bauman, Michael K Gibson
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article
